Related Experiment Video

Updated: Apr 29, 2026

Orthotopic Implantation and Peripheral Immune Cell Monitoring in the II-45 Syngeneic Rat Mesothelioma Model
09:31

Orthotopic Implantation and Peripheral Immune Cell Monitoring in the II-45 Syngeneic Rat Mesothelioma Model

Published on: October 2, 2015

8.8K

Immune therapies for malignant mesothelioma

Sabina Antonela Antoniu1, Gabriel Dimofte, Didona Ungureanu

  • 1Palliative Care-Interdisciplinary Department, Faculty of Medicine, University of Medicine and Pharmacy "Grigore T Popa", 16 Universitaţii Str, 700115, Iaşi, Romania.

Expert Review of Anticancer Therapy
|May 17, 2014
PubMed

Insights

Malignant mesothelioma (MM) treatments are limited. Immune therapies targeting mesothelin show promise for halting this rare cancer

Area of Science:

  • Oncology
  • Immunology

Background:

  • Malignant mesothelioma (MM) is a rare cancer affecting the pleura, pericardium, or peritoneum.
  • Current therapies for MM have limited efficacy and significant side effects.
  • There is a critical need for more targeted and effective treatments to control disease progression.

Purpose of the Study:

  • To review current immune-based therapies investigated for malignant mesothelioma.
  • To highlight mesothelin as a potential therapeutic target and biomarker for MM.

Main Methods:

  • Literature review of experimental and early clinical studies on MM immune therapies.
  • Focus on therapies targeting MM cell structures, particularly mesothelin.

Main Results:

  • Immune therapies demonstrate inhibitory potential in preclinical and early clinical MM studies.
  • Mesothelin is identified as a promising therapeutic target and a biomarker for MM activity.

Conclusions:

  • Immune therapies targeting mesothelin represent a promising avenue for novel MM treatments.
  • Further investigation into mesothelin-directed therapies is warranted for improved MM patient outcomes.
Keywords:
antibodiesimmunotoxinmesothelinmesotheliomavaccines

More Related Videos

Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines08:01

Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines

Published on: April 21, 2022

1.6K
Implantation and Monitoring by PET/CT of an Orthotopic Model of Human Pleural Mesothelioma in Athymic Mice07:54

Implantation and Monitoring by PET/CT of an Orthotopic Model of Human Pleural Mesothelioma in Athymic Mice

Published on: December 21, 2019

6.3K

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.5K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.0K
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.3K
Cancer Therapies02:49

Cancer Therapies

2.4K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.3K